Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

4th Inflammasome Therapeutics Summit

Evvnt Promotion / evvnt
-
29.11.2022 - 01.12.2022  Boston Park Plaza, 50 Park Plaza, 02116 Boston, USA
Time: 09:00 to 16:30
 
Temi della conferenza
The 4th Inflammasome Therapeutics Summit is the only industry-led forum uniting large pharma, biotechs, and academic KOLs, with the common goal of accelerating the practical translation and clinical development of inflammasome-targeted drugs, which are shaking up the immunology R and D landscape.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1252816-3?pid=4832

Speakers: Alan Watt, Chief Scientific Officer, NodThera, Bruno Reversade, Professor and Director, Laboratory of Human Genetics and Therapeutics GIS and IMCB, A*STAR, and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1252816-2?pid=4832
Ms. Jessica Durston
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2199.00 - USD 5696.00
I partecipanti attesi
1000 - 1000
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Helix - Forschung & Beratung WienÖsterreichische Akademie der ÄrzteAMREF - African Medical and Research FoundationnewTreeHilfswerk AustriaÖsterreichische Gesellschaft für Public HealthSwiss Tropical and Public Health InstituteAnästhesie in Entwicklungsländern e. V.